Pei-Jung Lin1, Yue Zhong2, Howard M Fillit3, Joshua T Cohen2, Peter J Neumann2. 1. Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA, USA. Electronic address: plin@tuftsmedicalcenter.org. 2. Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA, USA. 3. The Alzheimer's Drug Discovery Foundation, New York, NY, USA.
Abstract
INTRODUCTION: Medicare beneficiaries with Alzheimer's disease and related dementias (ADRDs) may have more potentially avoidable hospitalizations and readmissions than people without dementia. These hospitalizations may be indicative of access barriers, problems in continuity of care, inefficient resource use, and poor patient outcomes. METHODS: We examined national frequency and costs of ambulatory care sensitive condition hospitalizations and unplanned, all-cause, and condition-specific 30-day readmissions in >2.7 million fee-for-service ADRD patients using 2013 Medicare claims data. RESULTS: In 2013, 410,000 Medicare ADRD patients had ambulatory care sensitive condition hospitalizations or unplanned 30-day readmissions costing $4.7 billion. One in 10 ADRD patients were hospitalized for a potentially avoidable condition. Almost one in five hospitalized ADRD patients had an unplanned 30-day readmission. Readmission rates were highest among ADRD patients initially hospitalized for heart failure (22%) and chronic obstructive pulmonary disease (21%). DISCUSSION: Our findings may suggest potential deficiencies in ambulatory care and postdischarge care related to managing comorbidities among Medicare fee-for-service ADRD patients.
INTRODUCTION: Medicare beneficiaries with Alzheimer's disease and related dementias (ADRDs) may have more potentially avoidable hospitalizations and readmissions than people without dementia. These hospitalizations may be indicative of access barriers, problems in continuity of care, inefficient resource use, and poor patient outcomes. METHODS: We examined national frequency and costs of ambulatory care sensitive condition hospitalizations and unplanned, all-cause, and condition-specific 30-day readmissions in >2.7 million fee-for-service ADRD patients using 2013 Medicare claims data. RESULTS: In 2013, 410,000 Medicare ADRD patients had ambulatory care sensitive condition hospitalizations or unplanned 30-day readmissions costing $4.7 billion. One in 10 ADRD patients were hospitalized for a potentially avoidable condition. Almost one in five hospitalized ADRD patients had an unplanned 30-day readmission. Readmission rates were highest among ADRD patients initially hospitalized for heart failure (22%) and chronic obstructive pulmonary disease (21%). DISCUSSION: Our findings may suggest potential deficiencies in ambulatory care and postdischarge care related to managing comorbidities among Medicare fee-for-service ADRD patients.
Authors: William James Deardorff; Phillip L Liu; Richard Sloane; Courtney Van Houtven; Carl F Pieper; Susan Nicole Hastings; Harvey J Cohen; Heather E Whitson Journal: J Am Geriatr Soc Date: 2019-03-29 Impact factor: 5.562
Authors: Pei-Jung Lin; Yingying Zhu; Natalia Olchanski; Joshua T Cohen; Peter J Neumann; Jessica D Faul; Howard M Fillit; Karen M Freund Journal: JAMA Netw Open Date: 2022-06-01
Authors: Miriam Ryvicker; Yolanda Barrón; Shivani Shah; Stanley M Moore; James M Noble; Kathryn H Bowles; Jacqueline Merrill Journal: J Appl Gerontol Date: 2021-03-20
Authors: Oleg Zaslavsky; Onchee Yu; Rod L Walker; Paul K Crane; Shelly L Gray; Tatiana Sadak; Soo Borson; Eric B Larson Journal: J Gerontol A Biol Sci Med Sci Date: 2021-10-13 Impact factor: 6.053
Authors: Chenjuan Ma; Margaret V McDonald; Penny H Feldman; Sarah Miner; Simon Jones; Allison Squires Journal: Med Care Date: 2021-10-01 Impact factor: 3.178
Authors: Edwin van Wijngaarden; David Q Rich; Wangjian Zhang; Sally W Thurston; Shao Lin; Daniel P Croft; Stefania Squizzato; Mauro Masiol; Philip K Hopke Journal: Ann Epidemiol Date: 2020-09-30 Impact factor: 3.797